GGrantIndex
← Leaderboards

Pamela Susan Douglas

Duke University

$66,022,992
Attributed
$107,539,023
Total exposure
7
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $18.5M · FY200925
$20M$15M$10M$5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$107,389,115 · 6
FDA$149,908 · 1

By mechanism

U01$52,350,597 · 1
R01$36,932,887 · 3
UG3$18,105,631 · 2
R24$149,908 · 1

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Myocardial Infarction

Research focus

Myocardial InfarctionEventParticipantImageCardiovascular SystemHigh RiskEnrollmentCharacteristicsCardiacNational Heart, Lung, And Blood InstituteRisk FactorsAngiographyPathway InteractionsCardiovascular DiseasesCessation Of LifeCoronaryResponseHeart DiseasesMediatingUnited States National Institutes Of HealthHeartMortalityStrokeCoronary Arteriosclerosis

Grant awards (30)

1/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis$3,886,403
UG3 · FY2025 · HL
1/2 REPRIEVE Extension for Trial Completion$2,903,944
UG3 · FY2025 · HL
Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO$1,053,689
R01 · FY2025 · HL
1/2 REPRIEVE Extension for Trial Completion$4,747,407
UG3 · FY2024 · HL
Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO$1,128,497
R01 · FY2024 · HL
1/2 REPRIEVE Extension for Trial Completion$6,567,877
UG3 · FY2023 · HL
Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO$967,976
R01 · FY2023 · HL
Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO$577,891
R01 · FY2023 · HL
Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO$1,133,010
R01 · FY2022 · HL
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$610,178
R01 · FY2022 · HL
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,279,576
R01 · FY2021 · HL
REPRIEVE - CCC - Lead Application$1,210,912
U01 · FY2021 · HL
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,438,818
R01 · FY2020 · HL
REPRIEVE COVID-19 Administrative Supplement$1,210,912
U01 · FY2020 · HL
REPRIEVE - CCC - Lead Application$7,726,001
U01 · FY2019 · HL
REPRIEVE - CCC - Lead Application$4,393,652
U01 · FY2019 · HL
Clinical and Molecular Epidemiology of High Risk Coronary Plaque$1,485,906
R01 · FY2019 · HL
Administrative Supplement to Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)$13,774,000
U01 · FY2018 · HL
REPRIEVE - CCC - Lead Application$4,687,954
U01 · FY2018 · HL
REPRIEVE - CCC - Lead Application$4,924,231
U01 · FY2017 · HL
REPRIEVE - CCC - Lead Application$4,994,783
U01 · FY2016 · HL
REPRIEVE - CCC - Lead Application$3,367,267
U01 · FY2015 · HL
REPRIEVE - CCC - Lead Application$6,060,885
U01 · FY2014 · HL
PROMISE Trial: Clinical Coordinating Center$2,084,633
R01 · FY2014 · HL · contact PI
PROMISE Trial: Clinical Coordinating Center$4,579,259
R01 · FY2013 · HL · contact PI
PROMISE Trial: Clinical Coordinating Center$4,000,000
R01 · FY2012 · HL · contact PI
PROMISE Trial: Clinical Coordinating Center$2,980,313
R01 · FY2012 · HL · contact PI
Data Concepts and Terminology Standards in Cardiovascular Imaging$149,908
R24 · FY2012 · FD · contact PI
PROMISE Trial: Clinical Coordinating Center$8,046,691
R01 · FY2010 · HL · contact PI
PROMISE Trial: Clinical Coordinating Center$5,566,450
R01 · FY2009 · HL · contact PI